BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 2467687)

  • 1. The prognostic value of a response to chemotherapy given before radiotherapy in advanced cancer of cervix.
    Symonds RP; Burnett RA; Habeshaw T; Kaye SB; Snee MP; Watson ER
    Br J Cancer; 1989 Mar; 59(3):473-5. PubMed ID: 2467687
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined chemotherapy and radiotherapy in patients with advanced squamous carcinoma of the cervix (cis-platinum-bleomycin-vinblastine).
    Soeters R; Bloch B; Levin W; Dehaeck CM; Goldberg G
    Gynecol Oncol; 1989 Apr; 33(1):44-5. PubMed ID: 2467844
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Short duration neoadjuvant chemotherapy followed by radiotherapy for advanced carcinoma of the cervix: results and prognostic variables.
    Seoud M; Geara FB; Shamseddine A; Salem Z; Khalil A
    Eur J Gynaecol Oncol; 2003; 24(2):163-8. PubMed ID: 12701970
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A randomized study of primary bleomycin, vincristine, mitomycin and cisplatin (BOMP) chemotherapy followed by radiotherapy versus radiotherapy alone in stage IIIB and IVA squamous cell carcinoma of the cervix.
    Tabata T; Takeshima N; Nishida H; Hirai Y; Hasumi K
    Anticancer Res; 2003; 23(3C):2885-90. PubMed ID: 12926129
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combination chemotherapy prior to radical radiotherapy for stage III and IV carcinoma of the cervix.
    Symonds RP; Habeshaw T; Watson ER; Kaye SB
    Clin Radiol; 1987 May; 38(3):273-4. PubMed ID: 2438078
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Experience with bleomycin, ifosfamide, and cisplatin in primary and recurrent cervical cancer.
    Buxton EJ
    Semin Oncol; 1992 Apr; 19(2 Suppl 5):9-17; discussion 17-8. PubMed ID: 1384148
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Randomized trial of initial chemotherapy in 151 locally advanced carcinoma of the cervix (T2b-N1, T3b, MO)].
    Chauvergne J; Rohart J; Héron JF; Aymé Y; Berlié J; Fargeot P; George M; Lebrun-Jezekova D; Pigneux J; Chenal C
    Bull Cancer; 1990; 77(10):1007-24. PubMed ID: 2249011
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preliminary results of concurrent radiotherapy and chemotherapy with cis-platinum, vincristine, and bleomycin in bulky, advanced cervical carcinoma: a pilot study.
    Chang HC; Lai CH; Chen MS; Chao AS; Chen LH; Soong YK
    Gynecol Oncol; 1992 Feb; 44(2):182-8. PubMed ID: 1371978
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemotherapy for advanced and/or recurrent cervical cancer.
    Lahousen M; Pickel H; Tamussino K
    Arch Gynecol; 1987; 240(4):247-52. PubMed ID: 2440389
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radiotherapy and neoadjuvant chemotherapy for cervical carcinoma. A randomized multicenter study of sequential cisplatin and 5-fluorouracil and radiotherapy in advanced cervical carcinoma stage 3B and 4A.
    Sundfør K; Tropé CG; Högberg T; Onsrud M; Koern J; Simonsen E; Bertelsen K; Westberg R
    Cancer; 1996 Jun; 77(11):2371-8. PubMed ID: 8635109
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of carcinomas of the uterine cervix which remain bulky after initial external beam radiotherapy: a pilot study using integrated cytotoxic chemotherapy prior to brachytherapy.
    Tan LT; Jones B; Green JA; Kingston RE; Clark PI
    Br J Radiol; 1996 Feb; 69(818):165-71. PubMed ID: 8785646
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 'Quick course' neoadjuvant chemotherapy with cisplatin, bleomycin and vincristine in advanced cervical cancer.
    Singh KC; Agarwal A; Agarwal S; Rajaram S; Goel N; Agarwal N
    Gynecol Obstet Invest; 2004; 58(2):109-13. PubMed ID: 15192286
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cisplatin, vincristine, methotrexate and bleomycin (POMB) as initial or palliative chemotherapy for carcinoma of the cervix.
    Rustin GJ; Newlands ES; Southcott BM; Singer A
    Br J Obstet Gynaecol; 1987 Dec; 94(12):1205-11. PubMed ID: 2447933
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Five-year survival in patients given intra-arterial chemotherapy prior to radiotherapy for advanced squamous carcinoma of the cervix and vagina.
    Patton TJ; Kavanagh JJ; Delclos L; Wallace S; Haynie TP; Gershenson DM; Wharton JT; Bass S
    Gynecol Oncol; 1991 Jul; 42(1):54-9. PubMed ID: 1916511
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neoadjuvant chemotherapy with cisplatin, vincristine, and bleomycin and radical surgery in early-stage bulky cervical carcinoma.
    Chang HC; Lai CH; Chou PC; Tseng CJ; Chang TC; Hsueh S; Ho YS; Soong YK
    Cancer Chemother Pharmacol; 1992; 30(4):281-5. PubMed ID: 1379522
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Locally advanced carcinoma of the cervix uteri (stage IIB-IIIB TNM-UICC): radiotherapy combined with simultaneous daily low-dose platinum. Phase II study].
    Micheletti E; La Face B; Bianchi E; Cagna E; Sartori E
    Radiol Med; 1996 May; 91(5):628-34. PubMed ID: 8693131
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effective chemotherapy for advanced carcinoma of the cervix with bleomycin, cisplatin, vincristine, and methotrexate.
    Rosenthal CJ; Khulpateea N; Boyce J; Mehrotra S; Tamarin S
    Cancer; 1983 Dec; 52(11):2025-30. PubMed ID: 6194875
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neoadjuvant chemotherapy with vincristine and cisplatin followed by radical hysterectomy and pelvic lymphadenectomy for FIGO stage IB bulky cervical cancer: a Gynecologic Oncology Group pilot study.
    Eddy GL; Manetta A; Alvarez RD; Williams L; Creasman WT
    Gynecol Oncol; 1995 Jun; 57(3):412-6. PubMed ID: 7774847
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A phase II trial of less than 7 weeks of concomitant cisplatin-paclitaxel chemoradiation in locally advanced cervical cancer.
    Martínez-Monge R; Gaztañaga M; Aramendía JM; Cambeiro M; Arbea L; Espinós J; Aristu JJ; Jurado M
    Int J Gynecol Cancer; 2010 Jan; 20(1):133-40. PubMed ID: 20130514
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A phase II trial of mitomycin, vincristine, bleomycin, and cisplatin (MOBP) as neoadjuvant therapy in high-risk cervical carcinoma.
    Weiner SA; Aristizabal S; Alberts DS; Surwit EA; Deatherage-Deuser K
    Gynecol Oncol; 1988 May; 30(1):1-6. PubMed ID: 2452769
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.